By simulating various scenarios, predictive models help public health officials weigh the trade-offs between different ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Now is the time for policy makers, payers, health systems, and clinicians to act decisively by extending AHCaH, evaluating ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Health Affairs' Jeff Byers welcomes Farzad Mostashari, founder & CEO of Aledade and the former National Coordinator for ...

Hello and welcome to Health Affairs This Week. I'm your host Jeff Beyers. We're recording on 05/01/2025. Just as a heads up, if you haven't already heard, we have an insider event happening on May 29.

This article is the latest in the Health Affairs Forefront featured topic, Accountable Care for Population Health, featuring analysis and discussion of how to understand, design, support, and ...